NAPHTHALINDERIVATE, DIE SICH AN DEN EP4?REZEPTOR BINDEN

Compounds of formula (I) and pharmaceutically acceptable derivatives thereof bind with high affinity to the EP4 receptor and are of use in the treatment or prevention of conditions such as a pain, inflammatory, immunological, bone, neurodegenerative or renal disorder.

Saved in:
Bibliographic Details
Main Authors WALKER, ANN LOUISE, SHANAHAN, STEPHEN EDWARD, GIBLIN, GERARD MARTIN PAUL, ROOMANS, SUSAN, MASON, ANDREW MCMURTRIE, JONES, HAYDN TERENCE, MILLER, NEIL DEREK
Format Patent
LanguageGerman
Published 21.05.2008
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:Compounds of formula (I) and pharmaceutically acceptable derivatives thereof bind with high affinity to the EP4 receptor and are of use in the treatment or prevention of conditions such as a pain, inflammatory, immunological, bone, neurodegenerative or renal disorder.
Bibliography:Application Number: DE20016030256T